EA200100269A1 - Иммуногенные липосомные композиции - Google Patents
Иммуногенные липосомные композицииInfo
- Publication number
- EA200100269A1 EA200100269A1 EA200100269A EA200100269A EA200100269A1 EA 200100269 A1 EA200100269 A1 EA 200100269A1 EA 200100269 A EA200100269 A EA 200100269A EA 200100269 A EA200100269 A EA 200100269A EA 200100269 A1 EA200100269 A1 EA 200100269A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- immunogenic
- liposomic
- compositions
- liposomic compositions
- antigenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
Данное изобретение относится к иммуногенной липосомной композиции, включающей пузырекобразующие липиды и антигенную конструкцию, включающую одну или несколько антигенных детерминант и гидрофобную область.Отчет о международном поиске был опубликован 2000.11.23.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10135198P | 1998-09-22 | 1998-09-22 | |
US40072399A | 1999-09-21 | 1999-09-21 | |
PCT/US1999/020880 WO2000016746A2 (en) | 1998-09-22 | 1999-09-22 | Immunogenic liposome compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200100269A1 true EA200100269A1 (ru) | 2001-12-24 |
EA004797B1 EA004797B1 (ru) | 2004-08-26 |
Family
ID=26798150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100269A EA004797B1 (ru) | 1998-09-22 | 1999-09-22 | Иммуногенные липосомные композиции |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1115382B1 (ru) |
JP (1) | JP2002526436A (ru) |
KR (1) | KR100592825B1 (ru) |
CN (1) | CN1555254A (ru) |
AP (1) | AP2010A (ru) |
AT (1) | ATE468108T1 (ru) |
AU (1) | AU766772B2 (ru) |
BG (1) | BG65675B1 (ru) |
BR (1) | BR9914004A (ru) |
CA (1) | CA2344173C (ru) |
CY (1) | CY1110718T1 (ru) |
CZ (1) | CZ20011013A3 (ru) |
DE (1) | DE69942393D1 (ru) |
DK (1) | DK1115382T3 (ru) |
EA (1) | EA004797B1 (ru) |
EE (1) | EE200100168A (ru) |
ES (1) | ES2345695T3 (ru) |
GE (1) | GEP20053444B (ru) |
HK (1) | HK1039064A1 (ru) |
HU (1) | HUP0105391A3 (ru) |
ID (1) | ID29082A (ru) |
IL (2) | IL141675A0 (ru) |
MX (1) | MXPA01002973A (ru) |
NO (1) | NO330685B1 (ru) |
NZ (2) | NZ510442A (ru) |
OA (1) | OA11657A (ru) |
PL (1) | PL206260B1 (ru) |
SK (1) | SK287670B6 (ru) |
UA (1) | UA75327C2 (ru) |
WO (1) | WO2000016746A2 (ru) |
ZA (1) | ZA200101829B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1868651A4 (en) * | 2005-04-12 | 2010-10-06 | Univ Duke | METHOD FOR INDUCING ANTIBODIES THAT NEUTRALIZE THE HUMAN IMMUNODEFICIENCY VIRUS |
CN102448488B (zh) | 2009-06-04 | 2014-10-15 | 独立行政法人产业技术综合研究所 | 支原体感染症用疫苗 |
US20140287022A1 (en) * | 2011-04-26 | 2014-09-25 | Molecular Express, Inc. | Liposomal formulations |
US10076567B2 (en) | 2013-09-27 | 2018-09-18 | Duke University | MPER-liposome conjugates and uses thereof |
IL302880A (en) * | 2017-04-04 | 2023-07-01 | Avidea Tech Inc | Peptide-based ingredients, production methods, and their uses for inducing an immune response |
KR20240033309A (ko) * | 2022-09-05 | 2024-03-12 | 주식회사 차백신연구소 | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
SE462375B (sv) * | 1985-10-15 | 1990-06-18 | Morgaardshammar Ab Centro | Traadblock |
ES2032776T3 (es) * | 1986-05-20 | 1993-03-01 | Wako Pure Chemical Industries, Ltd. | Nuevos liposomas funcionalizados y un procedimiento para su produccion. |
FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
-
1999
- 1999-09-02 ID IDW20010900A patent/ID29082A/id unknown
- 1999-09-22 JP JP2000573707A patent/JP2002526436A/ja active Pending
- 1999-09-22 CA CA2344173A patent/CA2344173C/en not_active Expired - Fee Related
- 1999-09-22 MX MXPA01002973A patent/MXPA01002973A/es not_active IP Right Cessation
- 1999-09-22 CN CNA99811216XA patent/CN1555254A/zh active Pending
- 1999-09-22 GE GE4350A patent/GEP20053444B/en unknown
- 1999-09-22 NZ NZ510442A patent/NZ510442A/en not_active IP Right Cessation
- 1999-09-22 AU AU60351/99A patent/AU766772B2/en not_active Ceased
- 1999-09-22 HU HU0105391A patent/HUP0105391A3/hu unknown
- 1999-09-22 OA OA1200100075A patent/OA11657A/en unknown
- 1999-09-22 WO PCT/US1999/020880 patent/WO2000016746A2/en active IP Right Grant
- 1999-09-22 CZ CZ20011013A patent/CZ20011013A3/cs unknown
- 1999-09-22 AP APAP/P/2001/002096A patent/AP2010A/en active
- 1999-09-22 UA UA2001031606A patent/UA75327C2/uk unknown
- 1999-09-22 BR BR9914004-7A patent/BR9914004A/pt not_active IP Right Cessation
- 1999-09-22 IL IL14167599A patent/IL141675A0/xx active IP Right Revival
- 1999-09-22 SK SK322-2001A patent/SK287670B6/sk not_active IP Right Cessation
- 1999-09-22 EA EA200100269A patent/EA004797B1/ru not_active IP Right Cessation
- 1999-09-22 PL PL348604A patent/PL206260B1/pl not_active IP Right Cessation
- 1999-09-22 DE DE69942393T patent/DE69942393D1/de not_active Expired - Lifetime
- 1999-09-22 NZ NZ528055A patent/NZ528055A/en not_active IP Right Cessation
- 1999-09-22 EE EEP200100168A patent/EE200100168A/xx unknown
- 1999-09-22 DK DK99969329.4T patent/DK1115382T3/da active
- 1999-09-22 ES ES99969329T patent/ES2345695T3/es not_active Expired - Lifetime
- 1999-09-22 EP EP99969329A patent/EP1115382B1/en not_active Expired - Lifetime
- 1999-09-22 AT AT99969329T patent/ATE468108T1/de active
- 1999-09-22 KR KR1020017003621A patent/KR100592825B1/ko not_active IP Right Cessation
-
2001
- 2001-02-27 IL IL141675A patent/IL141675A/en not_active IP Right Cessation
- 2001-03-05 ZA ZA200101829A patent/ZA200101829B/en unknown
- 2001-03-20 NO NO20011406A patent/NO330685B1/no not_active IP Right Cessation
- 2001-03-22 BG BG105372A patent/BG65675B1/bg unknown
-
2002
- 2002-01-17 HK HK02100385.1A patent/HK1039064A1/xx not_active IP Right Cessation
-
2010
- 2010-07-30 CY CY20101100715T patent/CY1110718T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400067A1 (ru) | Конъюгаты гксф | |
FR2810033B1 (fr) | Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations | |
DE69419519T2 (de) | Riechstoffe formulierungen | |
EA200100713A1 (ru) | Препаративная форма галантамина с регулируемым выделением | |
ATE367845T1 (de) | Riechstoffzusammensetzungen | |
PT758248E (pt) | Formulacoes para o factor ix | |
EA199900598A1 (ru) | Производные 1-арил- и пиридилпиразола с пестицидными свойствами | |
EA199901013A1 (ru) | Гели пролонгированного действия | |
TR28023A (tr) | Yüzeyaktif iyon cifti floresanli beyazlatici terkipleri. | |
DK1100789T3 (da) | Substituerede benzoylcyclohexandioner | |
ATE321534T1 (de) | Verbesserte liposomale formulierung | |
WO2001076369A3 (de) | Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften | |
CY1110718T1 (el) | Ανοσογονες λιποσωμικες συνθεσεις | |
BR0110577A (pt) | Decorina transgenicamente produzida | |
DE69736123D1 (de) | Verbesserte brennstoffestabilität aufweisende brennstoffezusammensetzungen | |
IT1231013B (it) | Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'. | |
EA199900235A1 (ru) | Аморфные бензотиофены, способы получения и способы применения | |
ATE120718T1 (de) | Herstellung von peroxidzusammensetzungen. | |
DE59709372D1 (de) | Riechstoffkompositionen enthaltend substituierte 2-Acetylbenzofurane | |
DE69931186D1 (de) | Herstellung von wasserlöslichen sulfonierten organophosphor-verbindungen | |
EA200200073A1 (ru) | Многодозовые эритропоэтиновые составы | |
DE60117465D1 (de) | Lipide mit aminoxygruppe | |
FI915801A0 (fi) | Komposition och foerfarande foer att foerhindra fluoros. | |
EE9900199A (et) | Putukatõrje mikroemulsioonkompositsioonid | |
DE69903914D1 (de) | Herstellung von 3-buten-1-ol aus 3,4-epoxy-1-buten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |